Serial 87587728
Live / Registered — Registered — partial Sections 8 & 15 accepted and acknowledged (as of 14 Jul 2026)
What this means for you
Registered since 15 Sept 2020. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 15 Sept 2030: the §8 & §9 renewal).
Record
- Serial number
- 87587728
- Registration number
- 6153611
- Mark type
- Design / logo
- Filed
- 29 Aug 2017
- Published for opposition
- 10 Apr 2018
- Registered
- 15 Sept 2020
- Next maintenance filing
- §8 & §9 renewal, due by 15 Sept 2030 (grace period to 15 Mar 2031)
- Attorney of record
- Jodi A. DeSchane
Goods and services
- Class 001 — Chemicals: Hyaluronic acid and the sodium salt therefrom, namely, sodium hyaluronate, sold as a raw chemical for use in manufacturing processes, namely, for use in compounding pharmaceuticals or cosmetics
- Class 005 — Pharmaceuticals: [ Pharmaceutical preparations containing hyaluronic acid, sodium hyaluronate, or a derivative of hyaluronic acid for use in eye surgery, repair of flexible tissue, and injectable drug delivery compounds used as a facilitating agent for other pharmaceuticals ]
- Class 035 — Advertising and business services: regulatory submission management, namely, assisting others in preparing documents and information for their filing of applications for new drugs and medical devices with governmental regulatory bodies
- Class 039 — Transportation and storage services: packaging of custom designed and manufactured pharmaceuticals for others, namely, filling syringes, vials and bags, labeling, pouching, and traying
- Class 040 — Treatment of materials: contract manufacturing in the field of fermentation services for microbial and yeast fermentation; custom formulation of pharmaceuticals
- Class 042 — Scientific and technological services: designing and developing pharmaceuticals; inspection of custom designed and manufactured pharmaceuticals
- Class 045 — Legal and security services: regulatory compliance consulting in the field of pharmaceuticals and medical devices
Owner
- Lifecore Biomedical, LLC, Chaska, MN, US
- Lifecore Biomedical, LLC, Chaska, MN, US
- Lifecore Biomedical, LLC, Chaska, MN, US
Prosecution history
- 14 Jul 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 14 Jul 2026 — REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 13 Jul 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 08 Apr 2026 — TEAS SECTION 8 & 15 RECEIVED
- 15 Sept 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 03 Jan 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 03 Jan 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 03 Jan 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 03 Jan 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 03 Jan 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 15 Sept 2020 — REGISTERED-PRINCIPAL REGISTER
- 11 Aug 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 10 Aug 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 14 Jul 2020 — ASSIGNED TO EXAMINER
- 22 Jun 2020 — STATEMENT OF USE PROCESSING COMPLETE